ALD518
ALD518-CLIN-009
Phase 2 mab terminated
Quick answer
ALD518 for Oral Mucositis is a Phase 2 program (mab) at CSL Behring GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CSL Behring GmbH
- Indication
- Oral Mucositis
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated